0.0330
+0.0330
(0.00%)
As of January 24 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Operating Cash Flow
-2,043.0840
-2,000.3000
-1,956.7790
-4,284.2660
-3,956.2550
Investing Cash Flow
-47.2860
-9.8920
-87.7950
-1,205.3690
-274.9080
Financing Cash Flow
2,194.7970
2,159.7620
2,068.1600
5,329.8840
4,616.0940
End Cash Position
144.0210
359.1030
209.7360
96.0430
419.8250
Interest Paid Supplemental Data
22.1770
17.4950
--
401.9900
491.3780
Capital Expenditure
--
-9.8920
-87.7950
-1,205.3690
-223.8540
Issuance of Capital Stock
2,329.3430
1,939.3430
1,528.1600
3,877.6340
1,759.4860
Issuance of Debt
--
250.6000
390.0000
1,400.0000
1,934.8910
Repayment of Debt
-39.1460
-30.1810
--
-487.7500
--
Free Cash Flow
-2,090.3700
-2,010.1920
-2,044.5740
-5,489.6350
-4,180.1090
8/31/2021 - 8/15/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MYCOF Mydecine Innovations Group Inc.
0.0036
0.00%
TRUFF Red Light Holland Corp.
0.0321
-8.81%
SNOA Sonoma Pharmaceuticals, Inc.
2.8200
-1.23%
AYTU Aytu BioPharma, Inc.
1.6998
-0.01%
SBFM Sunshine Biopharma, Inc.
2.8250
-1.57%
RDHL RedHill Biopharma Ltd.
6.48
+0.78%
ALKS Alkermes plc
31.52
+1.06%
AQST Aquestive Therapeutics, Inc.
3.0300
-1.94%
ETON Eton Pharmaceuticals, Inc.
17.09
+2.51%
ESPR Esperion Therapeutics, Inc.
2.0800
-0.95%